Lantern Pharma Inc. SEC filings LTRN
Lantern Pharma Inc. has 262 filings in SEC EDGAR's recent list, going back to Jan 14, 2019. Its latest annual report, Form ARS, was filed on Oct 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 13, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 4, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 23, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 15, 2026 | — |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 16, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 3, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 23, 2026 | — |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 9, 2026 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 18, 2025 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 18, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Aug 20, 2025 | Aug 19, 2025 |
| 3 | Initial insider ownership | Jul 30, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 13, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 13, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 13, 2025 | — |
| 4 | Insider transaction | Jun 13, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | May 29, 2025 | May 27, 2025 |
| 4 | Insider transaction | May 29, 2025 | May 27, 2025 |
| 144 | Notice of proposed sale | May 27, 2025 | — |
| 144 | Notice of proposed sale | May 27, 2025 | — |
| 144 | Notice of proposed sale | May 27, 2025 | — |
| 144 | Notice of proposed sale | May 27, 2025 | — |
| 144 | Notice of proposed sale | May 27, 2025 | — |
| 4 | Insider transaction | Jul 26, 2024 | Jul 24, 2024 |
| 4 | Insider transaction | Jul 17, 2024 | Jul 15, 2024 |
| 4 | Insider transaction | Jul 17, 2024 | Jul 15, 2024 |
| 4 | Insider transaction | Jul 17, 2024 | Jul 15, 2024 |
| 4 | Insider transaction | Jul 17, 2024 | Jul 15, 2024 |
| 4 | Insider transaction | Jul 17, 2024 | Jul 15, 2024 |
| 4 | Insider transaction | Jul 17, 2024 | Jul 15, 2024 |
| 4 | Insider transaction | Jul 17, 2024 | Jul 15, 2024 |
| 4 | Insider transaction | May 28, 2024 | May 23, 2024 |
| 4 | Insider transaction | May 28, 2024 | May 23, 2024 |
| 144 | Notice of proposed sale | Apr 26, 2024 | — |
| 144 | Notice of proposed sale | Apr 26, 2024 | — |
| 144 | Notice of proposed sale | Apr 26, 2024 | — |
| 144 | Notice of proposed sale | Apr 26, 2024 | — |
| 144 | Notice of proposed sale | Apr 26, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Mar 1, 2024 | — |
| 4 | Insider transaction | Feb 29, 2024 | Feb 27, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 27, 2024 |
| 144 | Notice of proposed sale | Feb 28, 2024 | — |
| 144 | Notice of proposed sale | Feb 28, 2024 | — |
| 144 | Notice of proposed sale | Feb 28, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| 4 | Insider transaction | Jan 19, 2024 | Jan 17, 2024 |
| 4 | Insider transaction | Jan 19, 2024 | Jan 17, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Dec 1, 2023 | — |
| 4 | Insider transaction | Dec 1, 2023 | Nov 29, 2023 |
| 4 | Insider transaction | Dec 1, 2023 | Nov 29, 2023 |
| SC 13G | Ownership over 5% (passive) | Nov 21, 2022 | — |
| 4 | Insider transaction | Nov 9, 2022 | Nov 8, 2022 |
| 4 | Insider transaction | Nov 9, 2022 | Nov 8, 2022 |
| 4 | Insider transaction | Oct 24, 2022 | Oct 20, 2022 |
| 4 | Insider transaction | Sep 7, 2022 | Sep 2, 2022 |
| 4 | Insider transaction | Sep 7, 2022 | Sep 2, 2022 |
| 4 | Insider transaction | Aug 9, 2022 | Aug 6, 2022 |
| 3 | Initial insider ownership | Jun 17, 2022 | Jun 8, 2022 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 22, 2022 | — |
| 4 | Insider transaction | Mar 21, 2022 | Mar 17, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 11, 2022 | — |
| 4 | Insider transaction | Nov 8, 2021 | Nov 4, 2021 |
| 4 | Insider transaction | Nov 8, 2021 | Nov 4, 2021 |
| 4 | Insider transaction | Nov 8, 2021 | Nov 4, 2021 |
| 4 | Insider transaction | Nov 8, 2021 | Nov 4, 2021 |
| 4 | Insider transaction | Nov 8, 2021 | Nov 4, 2021 |
| 4 | Insider transaction | Nov 2, 2021 | Oct 29, 2021 |
| 4 | Insider transaction | Nov 2, 2021 | Oct 29, 2021 |
| SC 13G | Ownership over 5% (passive) | Feb 16, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 16, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Jan 25, 2021 | — |
| 4 | Insider transaction | Jan 19, 2021 | Jan 14, 2021 |
| SC 13D | Ownership over 5% (active) | Jun 23, 2020 | — |
| SC 13D | Ownership over 5% (active) | Jun 23, 2020 | — |
| SC 13D | Ownership over 5% (active) | Jun 19, 2020 | — |
| 4 | Insider transaction | Jun 17, 2020 | Jun 15, 2020 |
| 4 | Insider transaction | Jun 16, 2020 | Jun 15, 2020 |
| 4 | Insider transaction | Jun 16, 2020 | Jun 15, 2020 |
| 4 | Insider transaction | Jun 15, 2020 | Jun 15, 2020 |
| 4 | Insider transaction | Jun 15, 2020 | Jun 15, 2020 |
| 4 | Insider transaction | Jun 15, 2020 | Jun 15, 2020 |
| 4 | Insider transaction | Jun 15, 2020 | Jun 15, 2020 |
| 4 | Insider transaction | Jun 15, 2020 | Jun 15, 2020 |
| 4 | Insider transaction | Jun 15, 2020 | Jun 15, 2020 |
| 4 | Insider transaction | Jun 15, 2020 | Jun 15, 2020 |
| 4 | Insider transaction | Jun 15, 2020 | Jun 15, 2020 |
| 4 | Insider transaction | Jun 15, 2020 | Jun 11, 2020 |
| 3 | Initial insider ownership | Jun 10, 2020 | Jun 10, 2020 |
| 3 | Initial insider ownership | Jun 10, 2020 | Jun 10, 2020 |
| 3 | Initial insider ownership | Jun 10, 2020 | Jun 10, 2020 |
| 3 | Initial insider ownership | Jun 10, 2020 | Jun 10, 2020 |
| 3 | Initial insider ownership | Jun 10, 2020 | Jun 10, 2020 |
| 3 | Initial insider ownership | Jun 10, 2020 | Jun 10, 2020 |
| 3 | Initial insider ownership | Jun 10, 2020 | Jun 10, 2020 |
| 3 | Initial insider ownership | Jun 10, 2020 | Jun 10, 2020 |
| 3 | Initial insider ownership | Jun 10, 2020 | Jun 10, 2020 |
| 3 | Initial insider ownership | Jun 10, 2020 | Jun 10, 2020 |
| 3 | Initial insider ownership | Jun 10, 2020 | Jun 10, 2020 |
| 3 | Initial insider ownership | Jun 10, 2020 | Jun 10, 2020 |
Showing 112 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LTRN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- TX
- Headquarters
- Dallas, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1763950
- Former names
- Lantern Pharma (until Jan 14, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.